Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Clindamycin hydrochloride
Vetoquinol Ireland Limited
QJ01FF01
Clindamycin hydrochloride
75 mg/tablet
Tablet
POM: Prescription Only Medicine as defined in relevant national legislation
clindamycin
Authorised
2000-09-01
Health Products Regulatory Authority 28 August 2019 CRN00987J Page 1 of 4 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Clindacyl 75 mg Tablets for dogs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: ACTIVE SUBSTANCE Clindamycin 75 mg (as Clindamycin Hydrochloride) For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM A round white tablet with a breakline on one side. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Clindacyl 75 mg Tablets are antibiotics indicated for the treatment of infected wounds, abscesses, pyoderma and oral cavity/dental infections caused by or associated with clindamycin-sensitive staphylococci, streptococci, pneumococci, bacteroidaceae, _Fusobacterium necrophorum, Clostridium perfringens _and osteomyelitis caused by _Staphylococcus aureus_. Clindacyl 75 mg Tablets can also be used to help provide antimicrobial cover during dental procedures. 4.3 CONTRAINDICATIONS Do not administer to animals with hypersensitivity to clindamycin and lincomycin preparations. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE During prolonged osteomyelitis therapy of one month or greater, periodic liver and kidney function tests and blood counts should be performed. Patients with severe renal and/or very severe hepatic disturbances accompanied by severe metabolic aberrations should be dosed with caution and should be monitored by serum examination during high dose clindamycin therapy. Treatment with clindamycin should be based on susceptibility testing. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Wash hands after the administration of the product. Persons with known hypersensitivity to lincosamides (lincomycin, clindamycin) should not handle the product. Health Products Regulatory Authority 28 August 2019 CRN00987J Page 2 of 4 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNE Read the complete document